Gibson Christopher 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Recursion (RXRX) Director Christopher Gibson Sells 22,821 Shares
What Happened
Christopher Gibson, a director of Recursion Pharmaceuticals (RXRX), had 22,821 shares withheld on May 15, 2026 to satisfy tax withholding in connection with the net settlement of restricted stock units (RSUs). The withholding price was $3.04 per share, for a total value of approximately $69,376. This transaction is a disposition via tax withholding (transaction code F), a routine administrative event rather than an open‑market sale.
Key Details
- Transaction date: May 15, 2026; Form 4 filed May 19, 2026.
- Shares withheld/disposed: 22,821 at $3.04 per share; total value ≈ $69,376.
- Transaction code: F — shares withheld to satisfy tax withholding on RSU net settlement (see footnote F1).
- Shares owned after transaction: Not specified in this filing.
- Notable footnotes in the filing: F1 (withholding to satisfy tax obligations). Other footnotes (F2–F10) in the filing describe share class conversion rights, holdings through LLCs/trust, and various option vesting schedules for the reporting person.
Context
Net settlement/tax withholding of RSUs means a portion of vested shares are surrendered to the company to cover taxes; these are administrative dispositions and are common after vesting. Such withholdings generally do not signal insider sentiment in the same way that open‑market purchases might.
Insider Transaction Report
- Tax Payment
Class A Common Stock
[F1]2026-05-15$3.04/sh−22,821$69,376→ 883,735 total
- 4,343,334
Class B Common Stock
[F2]Exercise: $0.00→ Class A Common Stock (0 underlying) - 386,000(indirect: By LLC)
Class B Common Stock
[F2][F3]Exercise: $0.00→ Class A Common Stock (0 underlying) - 388,000(indirect: By LLC)
Class B Common Stock
[F2][F4]Exercise: $0.00→ Class A Common Stock (0 underlying) - 50,000(indirect: By Trust)
Class B Common Stock
[F2][F5]Exercise: $0.00→ Class A Common Stock (0 underlying) - 1,050,567
Stock Option (Right to Buy)
[F6]Exercise: $7.25Exp: 2035-02-03→ Class A Common Stock (0 underlying) - 666,898
Stock Option (Right to Buy)
[F7]Exercise: $10.09Exp: 2034-02-09→ Class A Common Stock (0 underlying) - 813,600
Stock Option (Right to Buy)
[F8]Exercise: $8.55Exp: 2033-02-01→ Class A Common Stock (0 underlying) - 399,002
Stock Option (Right to Buy)
[F9]Exercise: $11.40Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 5,436
Stock Option (Right to Buy)
Exercise: $11.40From: 2022-02-04Exp: 2032-02-04→ Class A Common Stock (0 underlying) - 282,500
Stock Option (Right to Buy)
[F10]Exercise: $2.48Exp: 2030-12-30→ Class A Common Stock (0 underlying)
Footnotes (10)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F10]The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
- [F2]Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- [F3]The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
- [F4]The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
- [F5]The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
- [F6]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F7]The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F8]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F9]The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.